15 results on '"Pixner, Thomas"'
Search Results
2. Effects of Movement Behaviors on Overall Health and Appetite Control: Current Evidence and Perspectives in Children and Adolescents
- Author
-
Julian, Valérie, Haschke, Ferdinand, Fearnbach, Nicole, Gomahr, Julian, Pixner, Thomas, Furthner, Dieter, Weghuber, Daniel, and Thivel, David
- Published
- 2022
- Full Text
- View/download PDF
3. Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes.
- Author
-
Pixner, Thomas, Chaikouskaya, Tatsiana, Lauth, Wanda, Zimmermann, Georg, Mörwald, Katharina, Lischka, Julia, Furthner, Dieter, Awender, Elisabeth, Geiersberger, Sabine, Maruszczak, Katharina, Forslund, Anders, Anderwald, Christian-Heinz, Cadamuro, Janne, Weghuber, Daniel, and Bergsten, Peter
- Subjects
ADOLESCENT obesity ,CHILDHOOD obesity ,TYPE 2 diabetes ,OVERWEIGHT children ,GLUCAGON ,BLOOD sugar ,GLYCOSYLATED hemoglobin - Abstract
Background: Fasting levels of glucagon are known to be elevated in youth and adults with type 2 diabetes mellitus (T2D). Children and adolescents with obesity were previously reported to show increasing fasting and post-glucose-challenge hyperglucagonemia across the spectrum of glucose tolerance, while no data are available in those with impaired fasting glucose (IFG). Materials and methods: Individuals from the Beta-JUDO study population (Uppsala and Salzburg 2010-2016) (n=101, age 13.3 ± 2.8, m/f=50/51) were included (90 with overweight or obesity, 11 with normal weight). Standardized OGTT were performed and plasma glucose, glucagon and insulin concentrations assessed at baseline, 5, 10, 15, 30, 60, 90 and 120 minutes. Patients were grouped according to their glycemic state in six groups with normal glucose metabolism (NGM) and normal weight (NG-NW), NGM with obesity or overweight (NG-O), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), IGT+IFG and T2D, and in two groups with NGM and impaired glucose metabolism (IGM), for statistical analysis. Results and conclusion: Glucagon concentrations were elevated in young normoglycemic individuals with overweight or obesity (NG-O) compared to normoglycemic individuals with normal weight. Glucagon levels, fasting and dynamic, increased with progressing glycemic deterioration, except in IFG, where levels were comparable to those in NG-O. All glycemic groups showed an overall suppression of glucagon during OGTT. An initial increase of glucagon could be observed in T2D. In T2D, glucagon showed a strong direct linear correlation with plasma glucose levels during OGTT. Glucagon in adolescents, as in adults, may play a role in the disease progression of T2D. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The relationship between glucose and the liver-alpha cell axis - A systematic review.
- Author
-
Pixner, Thomas, Stummer, Nathalie, Schneider, Anna Maria, Lukas, Andreas, Gramlinger, Karin, Julian, Valérie, Thivel, David, Mörwald, Katharina, Mangge, Harald, Dalus, Christopher, Aigner, Elmar, Furthner, Dieter, Weghuber, Daniel, and Maruszczak, Katharina
- Subjects
NON-alcoholic fatty liver disease ,AMINO acid metabolism ,GLUCOSE ,PANCREATIC secretions ,TYPE 2 diabetes - Abstract
Until recently, glucagon was considered a mere antagonist to insulin, protecting the body from hypoglycemia. This notion changed with the discovery of the liver-alpha cell axis (LACA) as a feedback loop. The LACA describes how glucagon secretion and pancreatic alpha cell proliferation are stimulated by circulating amino acids. Glucagon in turn leads to an upregulation of amino acid metabolism and ureagenesis in the liver. Several increasingly common diseases (e.g., non-alcoholic fatty liver disease, type 2 diabetes, obesity) disrupt this feedback loop. It is important for clinicians and researchers alike to understand the liver-alpha cell axis and the metabolic sequelae of these diseases. While most of previous studies have focused on fasting concentrations of glucagon and amino acids, there is limited knowledge of their dynamics after glucose administration. The authors of this systematic review applied PRISMA guidelines and conducted PubMed searches to provide results of 8078 articles (screened and if relevant, studied in full). This systematic review aims to provide better insight into the LACA and its mediators (amino acids and glucagon), focusing on the relationship between glucose and the LACA in adult and pediatric subjects. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
- Author
-
Maruszczak, Katharina, Radzikowski, Konrad, Schütz, Sebastian, Mangge, Harald, Bergsten, Peter, Forslund, Anders, Manell, Hannes, Pixner, Thomas, Ahlström, Håkan, Kullberg, Joel, Mörwald, Katharina, and Weghuber, Daniel
- Subjects
NON-alcoholic fatty liver disease ,FATTY liver ,MAGNETIC resonance imaging ,GLUCOSE tolerance tests ,CHILDHOOD obesity - Abstract
Objective: Over the years, non-alcoholic fatty liver (NAFLD) disease has progressed to become the most frequent chronic liver disease in children and adolescents. The full pathology is not yet known, but disease progression leads to cirrhosis and hepatocellular carcinoma. Risk factors included hypercaloric diet, obesity, insulin resistance and genetics. Hyperglucagonemia appears to be a pathophysiological consequence of hepatic steatosis, thus, the hypothesis of the study is that hepatic fat accumulation leads to increased insulin resistance and impaired glucagon metabolism leading to hyperglucagonemia in pediatric NAFLD. Methods: 132 children and adolescents between 10 and 18 years, with varying degrees of obesity, were included in the study. Using Magnetic Resonance Imaging (MRI) average liver fat was determined, and patients were stratified as NAFLD (>5% liver fat content) and non-NAFLD (<5%). All patients underwent a standardized oral glucose tolerance test (OGTT). Additionally, anthropometric parameters (height, weight, BMI, waist circumference, hip circumference) such as lab data including lipid profile (triglycerides, HDL, LDL), liver function parameters (ALT, AST), uric acid, glucose metabolism (fasting insulin and glucagon, HbA1c, glucose 120 min) and indices evaluating insulin resistance (HIRI, SPISE, HOMA-IR, WBISI) were measured. Results: Children and adolescents with NAFLD had significantly higher fasting glucagon values compared to the non-NAFLD cohort (p=0.0079). In the NAFLD cohort univariate analysis of fasting glucagon was associated with BMI-SDS (p<0.01), visceral adipose tissue volume (VAT) (p<0.001), average liver fat content (p<0.001), fasting insulin concentration (p<0.001), triglycerides (p<0.001) and HDL (p=0.034). This correlation equally applied to all insulin indices HOMA-IR, WBISI, HIRI (all p<0.001) and SPISE (p<0.002). Multivariate analysis (R² adjusted 0.509) for the same subgroup identified HIRI (p=0.003) and VAT volume (p=0.017) as the best predictors for hyperglucagonemia. Average liver fat content is predictive in pediatric overweight and obesity but not NAFLD. Conclusions: Children and adolescents with NAFLD have significantly higher fasting plasma glucagon values, which were best predicted by hepatic insulin resistance and visceral adipose tissue, but not average liver fat content. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Sedentary time has a stronger impact on metabolic health than moderate to vigorous physical activity in adolescents with obesity: a cross‐sectional analysis of the Beta‐JUDO study.
- Author
-
Julian, Valérie, Bergsten, Peter, Forslund, Anders, Ahlstrom, Hakan, Ciba, Iris, Dahlbom, Marie, Furthner, Dieter, Gomahr, Julian, Kullberg, Joel, Maruszczak, Katharina, Morwald, Katharina, Olsson, Roger, Pixner, Thomas, Schneider, Anna, Pereira, Bruno, Thivel, David, and Weghuber, Daniel
- Subjects
SEDENTARY lifestyles ,CHILDHOOD obesity ,CROSS-sectional method ,PHYSICAL activity ,METABOLIC disorders ,DESCRIPTIVE statistics ,INSULIN resistance ,ADOLESCENCE - Abstract
Summary: Background: Relationships between movement‐related behaviours and metabolic health remain underexplored in adolescents with obesity. Objectives: To compare profiles of sedentary time (more sedentary, SED+ vs. less sedentary, SED−), moderate to vigorous physical activity (MVPA) time (more active, MVPA+ vs. less active, MVPA−) and combinations of behaviours (SED−/MVPA+, SED−/MVPA−, SED+/MVPA+, SED+/MVPA−) in regard to metabolic health. Methods: One hundred and thirty‐four subjects (mean age 13.4 ± 2.2 yrs, mean body mass index [BMI] 98.9 ± 0.7 percentile, 48.5% females) underwent 24 h/7 day accelerometry, anthropometric, body composition, blood pressure (BP), lipid profile and insulin resistance (IR) assessments. Results: Metabolic health was better in SED− [lower fat mass (FM) percentage (p < 0.05), blood pressure (BP) (p < 0.05), homeostasis model assessment of insulin resistance (HOMA‐IR) (p < 0.001) and metabolic syndrome risk score (MetScore) (p < 0.001), higher high‐density lipoprotein‐cholesterol (HDL‐c) (p = 0.001)] vs. SED+ group and in MVPA+ [lower triglyceridemia (TG), (p < 0.05), HOMA‐IR (p < 0.01) and MetScore (p < 0.001), higher HDL‐c (p < 0.01)] vs. MVPA− group after adjustment with age, gender, maturation and BMI. SED−/MVPA+ group had the best metabolic health. While sedentary (p < 0.001) but also MVPA times (p < 0.001) were lower in SED−/MVPA− vs. SED+/MVPA+, SED−/MVPA− had lower FM percentage (p < 0.05), HOMA‐IR (p < 0.01) and MetScore (p < 0.05) and higher HDL‐c (p < 0.05), independently of BMI. Sedentary time was positively correlated with HOMA‐IR and Metscore and negatively correlated with HDL‐c after adjustment with MVPA (p < 0.05). MVPA was negatively correlated with HOMA‐IR, BP and MetScore and positively correlated with HDL‐c after adjustment with sedentary time (p < 0.05). Conclusion: Lower sedentary time is associated with a better metabolic health independently of MVPA and might be a first step in the management of pediatric obesity when increasing MVPA is not possible. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The lumbar sympathetic trunk: its visibility and distance to two anatomical landmarks
- Author
-
Feigl, Georg C., Kastner, Manuel, Ulz, Heimo, Breschan, Christian, Pixner, Thomas, Dreu, Manuel, Umschaden, Heinz W., and Likar, Rudolf
- Published
- 2013
- Full Text
- View/download PDF
8. The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population—A Review.
- Author
-
Pixner, Thomas, Stummer, Nathalie, Schneider, Anna Maria, Lukas, Andreas, Gramlinger, Karin, Julian, Valérie, Thivel, David, Mörwald, Katharina, Maruszczak, Katharina, Mangge, Harald, Gomahr, Julian, Weghuber, Daniel, and Furthner, Dieter
- Subjects
- *
NON-alcoholic fatty liver disease , *CHILD patients , *TRANS fatty acids , *WESTERN diet , *FAT , *MEDITERRANEAN diet , *GLYCEMIC index , *SATURATED fatty acids - Abstract
Paediatric non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in childhood. Obesity is the main risk factor. Nutrition and lifestyle are the key elements in preventing and treating NAFLD in the absence of approved drug therapy. Whilst recommendations and studies on macronutrients (carbohydrates, fat and protein) in adult NAFLD exist, the discussion of this topic in paediatric NAFLD remains contradictory. The purpose of this review is to provide state-of-the-art knowledge on the role of macronutrients in paediatric NAFLD regarding quality and quantity. PubMed was searched and original studies and review articles were included in this review. Fructose, sucrose, saturated fatty acids, trans-fatty acids and ω-6-fatty-acids are strongly associated with paediatric NAFLD. High consumption of fibre, diets with a low glycaemic index, mono-unsaturated-fatty-acids and ω-3-fatty-acids reduce the risk of childhood-onset NAFLD. Data regarding the role of dietary protein in NAFLD are contradictory. No single diet is superior in treating paediatric NAFLD, although the composition of macronutrients in the Mediterranean Diet appears beneficial. Moreover, the optimal proportions of total macronutrients in the diet of paediatric NAFLD patients are unknown. Maintaining a eucaloric diet and avoiding saturated fatty acids, simple sugars (mainly fructose) and a high-caloric Western Diet are supported by literature. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps.
- Author
-
Furthner, Dieter, Weghuber, Daniel, Dalus, Christopher, Lukas, Andreas, Stundner-Ladenhauf, Hannah N., Mangge, Harald, and Pixner, Thomas
- Subjects
NON-alcoholic fatty liver disease ,CHILDHOOD obesity ,OVERWEIGHT children ,CHILD patients ,DISEASE complications ,LIVER diseases ,FATTY liver - Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is the leading hepatic disease in children, ranging from steatosis to steatohepatitis and fibrosis. Age, sex, hormonal levels, pubertal stages, genetic risk- and epigenetic factors are among the many influencing factors. Appearing predominantly in children with obesity, but not exclusively, it is the liver's manifestation of the metabolic syndrome but can also exist as an isolated entity. Summary: Pediatric NAFLD differs from the adult phenotype. This narrative review on NAFLD in children with obesity provides an overview of the current knowledge on risk factors, screening, and diagnostic methods, as well state-of-the-art treatment. The recent discussion on the proposition of a new nomenclature – Metabolic [Dysfunction-] Associated Liver Disease – is featured, and current gaps of knowledge are discussed. Key Messages: Currently, there is no international consensus on screening and monitoring of pediatric NAFLD. With lifestyle interventions being the cornerstone of treatment, no registered pharmacological treatment for pediatric NAFLD is available. Development and validation of additional noninvasive biomarkers, scores and imaging tools suitable to subcategorize, screen and monitor pediatric patients are necessary. With a variety of upcoming and promising agents, clear recommendations for pediatric nonalcoholic steatohepatitis trials are urgently needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. The cleidoatlanticus muscle: a potential pitfall for the practice of ultrasound guided interscalene brachial plexus block
- Author
-
Feigl, Georg C. and Pixner, Thomas
- Published
- 2011
- Full Text
- View/download PDF
11. Association between Metabolic Syndrome Diagnosis and the Physical Activity—Sedentary Profile of Adolescents with Obesity: A Complementary Analysis of the Beta-JUDO Study.
- Author
-
Julian, Valérie, Ciba, Iris, Olsson, Roger, Dahlbom, Marie, Furthner, Dieter, Gomahr, Julian, Maruszczak, Katharina, Morwald, Katharina, Pixner, Thomas, Schneider, Anna, Pereira, Bruno, Duclos, Martine, Weghuber, Daniel, Thivel, David, Bergsten, Peter, and Forslund, Anders
- Abstract
Metabolic syndrome (MetS) is highly prevalent in children and adolescents with obesity and places them at an increased risk of cardiovascular-related diseases. However, the associations between objectively measured movement-related behaviors and MetS diagnosis remain unexplored in youths with obesity. The aim was to compare profiles of sedentary (SED) time (more sedentary, SED+ vs. less sedentary, SED−), moderate to vigorous physical activity (MVPA) time (more active, MVPA+ vs. less active, MVPA−) and combinations of behaviors (SED−/MVPA+, SED−/MVPA−, SED+/MVPA+, SED+/MVPA−) regarding the MetS diagnosis. One hundred and thirty-four adolescents with obesity (13.4 ± 2.2 years) underwent 24 h/7 day accelerometry, waist circumference (WC), blood pressure (BP), high-density lipoprotein-cholesterol (HDL-c), triglycerides (TG) and insulin-resistance (IR) assessments. Cumulative cardiometabolic risk was assessed by using (i) MetS status (usual dichotomic definition) and (ii) cardiometabolic risk z-score (MetScore, mean of standardized WC, BP, IR, TG and inverted HDL-c). SED− vs. SED+ and MVPA+ vs. MVPA− had lower MetS (p < 0.01 and p < 0.001) and MetScore (p < 0.001). SED−/MVPA+ had the lowest risk. While SED and MVPA times were lower in SED−/MVPA− vs. SED+/MVPA+ (p < 0.001), MetScore was lower in SED−/MVPA− independently of body mass index (BMI) (p < 0.05). MVPA, but not SED, time was independently associated with MetS diagnosis (p < 0.05). Both MVPA (p < 0.01) and SED times (p < 0.05) were associated with MetScore independently of each other. A higher MVPA and lower SED time are associated with lower cumulative cardiometabolic risk. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps.
- Author
-
Furthner, Dieter, Lukas, Andreas, Schneider, Anna Maria, Mörwald, Katharina, Maruszczak, Katharina, Gombos, Petra, Gomahr, Julian, Steigleder-Schweiger, Claudia, Weghuber, Daniel, and Pixner, Thomas
- Abstract
Carbohydrate counting (CHC) is the established form of calculating bolus insulin for meals in children with type 1 diabetes (T1DM). With the widespread use of continuous glucose monitoring (CGM) observation time has become gapless. Recently, the impact of fat, protein and not only carbohydrates on prolonged postprandial hyperglycaemia have become more evident to patients and health-care professionals alike. However, there is no unified recommendation on how to calculate and best administer additional bolus insulin for these two macronutrients. The aim of this review is to investigate: the scientific evidence of how dietary fat and protein influence postprandial glucose levels; current recommendations on the adjustment of bolus insulin; and algorithms for insulin application in children with T1DM. A PubMed search for all articles addressing the role of fat and protein in paediatric (sub-)populations (<18 years old) and a mixed age population (paediatric and adult) with T1DM published in the last 10 years was performed. Conclusion: Only a small number of studies with a very low number of participants and high degree of heterogeneity was identified. While all studies concluded that additional bolus insulin for (high) fat and (high) protein is necessary, no consensus on when dietary fat and/or protein should be taken into calculation and no unified algorithm for insulin therapy in this context exists. A prolonged postprandial observation time is necessary to improve individual metabolic control. Further studies focusing on a stratified paediatric population to create a safe and effective algorithm, taking fat and protein into account, are necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Combination of Variations of the Interscalene Gap as a Pitfall for Ultrasound-Guided Brachial Plexus Block.
- Author
-
Feigl, Georg Christoph and Pixner, Thomas
- Published
- 2011
- Full Text
- View/download PDF
14. Association between Metabolic Syndrome Diagnosis and the Physical Activity-Sedentary Profile of Adolescents with Obesity: A Complementary Analysis of the Beta-JUDO Study.
- Author
-
Julian V, Ciba I, Olsson R, Dahlbom M, Furthner D, Gomahr J, Maruszczak K, Morwald K, Pixner T, Schneider A, Pereira B, Duclos M, Weghuber D, Thivel D, Bergsten P, and Forslund A
- Subjects
- Accelerometry, Adolescent, Blood Pressure, Body Mass Index, Cardiovascular Diseases etiology, Child, Cholesterol, HDL blood, Female, Humans, Insulin Resistance, Male, Metabolic Syndrome prevention & control, Regression Analysis, Risk Factors, Triglycerides blood, Waist Circumference, Cardiovascular System metabolism, Exercise, Metabolic Syndrome diagnosis, Pediatric Obesity metabolism, Sedentary Behavior
- Abstract
Metabolic syndrome (MetS) is highly prevalent in children and adolescents with obesity and places them at an increased risk of cardiovascular-related diseases. However, the associations between objectively measured movement-related behaviors and MetS diagnosis remain unexplored in youths with obesity. The aim was to compare profiles of sedentary (SED) time (more sedentary, SED+ vs. less sedentary, SED-), moderate to vigorous physical activity (MVPA) time (more active, MVPA+ vs. less active, MVPA-) and combinations of behaviors (SED-/MVPA+, SED-/MVPA-, SED+/MVPA+, SED+/MVPA-) regarding the MetS diagnosis. One hundred and thirty-four adolescents with obesity (13.4 ± 2.2 years) underwent 24 h/7 day accelerometry, waist circumference (WC), blood pressure (BP), high-density lipoprotein-cholesterol (HDL-c), triglycerides (TG) and insulin-resistance (IR) assessments. Cumulative cardiometabolic risk was assessed by using (i) MetS status (usual dichotomic definition) and (ii) cardiometabolic risk z-score (MetScore, mean of standardized WC, BP, IR, TG and inverted HDL-c). SED- vs. SED+ and MVPA+ vs. MVPA- had lower MetS ( p < 0.01 and p < 0.001) and MetScore ( p < 0.001). SED-/MVPA+ had the lowest risk. While SED and MVPA times were lower in SED-/MVPA- vs. SED+/MVPA+ ( p < 0.001), MetScore was lower in SED-/MVPA- independently of body mass index (BMI) ( p < 0.05). MVPA, but not SED, time was independently associated with MetS diagnosis ( p < 0.05). Both MVPA ( p < 0.01) and SED times ( p < 0.05) were associated with MetScore independently of each other. A higher MVPA and lower SED time are associated with lower cumulative cardiometabolic risk.
- Published
- 2021
- Full Text
- View/download PDF
15. Clusterin expression in elastofibroma dorsi.
- Author
-
Aigelsreiter A, Pichler M, Pixner T, Janig E, Schuller M, Lackner C, Scheipl S, Beham A, and Regauer S
- Subjects
- Aged, Antigens, CD34 metabolism, Elastic Tissue metabolism, Elastic Tissue pathology, Fibroma etiology, Fibroma pathology, Humans, Middle Aged, Neoplasms etiology, Neoplasms pathology, Retrospective Studies, Scapula injuries, Soft Tissue Neoplasms etiology, Soft Tissue Neoplasms pathology, Vimentin metabolism, Wounds and Injuries complications, Clusterin metabolism, Fibroma metabolism, Neoplasms metabolism, Soft Tissue Neoplasms metabolism
- Abstract
Background: Elastofibroma dorsi is a benign soft tissue lesion composed of abnormal elastic fibers. Degenerated elastic fibers in skin and liver are associated with clusterin, an apoprotein that shares functional properties with small heat shock proteins. We evaluated the staining pattern and possible role of clusterin in elastofibroma dorsi., Material and Methods: Twenty-one subcutaneous elastofibromas from the scapular region were evaluated with Elastica van Gieson and Orcein stains, immunohistochemically with antibodies to clusterin, smooth muscle actin, S-100, vimentin and CD34 and correlated with clinical data with respect to physical trauma., Results: Clusterin correlated with the staining pattern of Elastica van Gieson and labelled abnormal broad coarse fibrillar and globular elastic fibers in all elastofibromas. Orcein stains additionally identified fine oxytalan fibers which were not stained by clusterin. Clusterin staining was observed only on the outside of the elastin fibers, while the cores of fibers and globules were unstained. 4/21 elastofibromas showed cellular nodules with a myxoid/collagenous stroma. The round to oval cells showed cytoplasmic staining with vimentin and clusterin; CD34 labelled mostly cell membranes. The cells lacked SMA and S-100 expression. The central areas of the nodules were devoid of elastic fibers, but the periphery contained coarse fibers and globules. 9/ 11 patients, for whom clinical data were available, reported trauma to the scapular region., Conclusion: Many investigated ED were associated with trauma, which supports a reactive/degenerative etiology of ED. The abnormal large elastic fibers in all ED were enveloped by clusterin. Clusterin deposition may protect elastic fibers from degradation and thus contribute indirectly to the tumor-like presentation of ED.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.